Prospective clinical evidence from over 1,000 pan-cancer patients: a complement to fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting.

导出 LinkOut

翻译打印收藏纠错

作者： Lijuan,He ^[1] ; Jize,Wang ^[1] ; Weigao,Pu ^[1] ; Haiyuan,Li ^[1] ; Ben,Liu ^[1] ; Zhuanfang,Wang ^[1] ; Qinying,Han ^[1] ; Yunpeng,Wang ^[1] ; Bo,Xu ^[1] ; Jike,Hu ^[1] ; Guodong,Sun ^[1] ; Hao,Chen ^[2]

作者单位： The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730030, China.;Department of Surgical Oncology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730030, China. ^[1] The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730030, China. ery_chenh@lzu.edu.cn.;Department of Surgical Oncology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730030, China. ery_chenh@lzu.edu.cn.;Gansu Provincial Key Laboratory of Environmental Oncology, Lanzhou, 730030, China. ery_chenh@lzu.edu.cn.;Humanized animal model laboratory, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730030, China. ery_chenh@lzu.edu.cn.;Shanghai Jiao Tong University School of Medicine, Shanghai, China. ery_chenh@lzu.edu.cn.;Shanghai General Hospital, Shanghai, China. ery_chenh@lzu.edu.cn. ^[2]

关键词 Chemotherapy-induced nausea and vomiting Fosaprepitant Pan-cancer Real world